New medicines with mass appeal will keep drug costs soaring
PRODUCT AND APPLICATION COMPANY 2005 PROJECTED SALES (MILLIONS)
CIALIS Erectile dysfunction Eli Lilly/ICOS $2,000 ARCOXIA Arthritis and pain Merck 2,000 VANLEV Hypertension Bristol-Myers Squibb 2,000 BEXTRA Arthritis and pain Pharmacia/Pfizer 2,000 CLARINEX Allergy Schering-Plough 2,000 CRESTOR Cholesterol reduction AstraZeneca 3,500
Data: SG Cowen Securities Corp.
Before it's here, it's on the Bloomberg Terminal. LEARN MORE